Christine Jacomet1, Angeline Guyot-Lénat2, Corinne Bonny3, Cécile Henquell4, Morgane Rude5, Sylviane Dydymski6, Jean-Alexandre Lesturgeon7, Céline Lambert8, Bruno Pereira8, Jeannot Schmidt2. 1. 1 Infectious Diseases Department, Clermont-Ferrand University Hospital, Clermont Ferrand F-63000, France cjacomet@chu-clermontferrand.fr. 2. 2 Clermont Ferrand and Riom Prisons Medical Units, Emergency Department, Clermont-Ferrand University Hospital, Clermont Ferrand F-63000, France. 3. 3 Hepatology Department, Clermont-Ferrand University Hospital, Clermont Ferrand F-63000, France. 4. 4 Virology Department, Clermont-Ferrand University Hospital, Clermont Ferrand F-63000, France. 5. 5 Emile Roux Centre, CDAG (Free anonymous screening centre), Clermont Ferrand F-63000, France. 6. 1 Infectious Diseases Department, Clermont-Ferrand University Hospital, Clermont Ferrand F-63000, France. 7. 6 Psychiatric Department, Sainte Marie Hospital, Clermont Ferrand F-63000, France. 8. 7 Clermont-Ferrand University Hospital, Biostatistic Unit (DRCI Clinical research and innovation service), Clermont Ferrand F-63000, France.
Abstract
OBJECTIVES: In 2010 only 30.9%, of the Puy-de-Dome prison detainees were screened for human immunodeficiency virus (HIV), hepatitis C virus (HCV) and hepatitis B virus (HBV). Our goal was then to promote these assesments, as well as to identify addictive behaviour using FAGERSTROM, Cannabis Abuse Screening Test and CAGE tests, diagnose fibrosis by means of Fibrometer or Fibroscan in hepatic virus carriers and heavy drinkers, and perform HBV vaccinations. SETTING: This prospective study of adult detainees in the prisons of Puy-de-Dome, France, took place from June 2012 to December 2013. RESULTS: Of the 702 incarcerated individuals, 396(56.4%) were screened and 357(50.9%) enrolled. HIV prevalence was 0.3%, HCV 4.7% and HBV 0.6%. While 234/294(79.6%) smokers and 115/145(79.3%) cannabis users were screened for dependence, excessive alcohol consumption was tested for in 91/179(50.8%) cases. Fibrosis was screened for in 75/80(93.7%) individuals selected with 16.0% presenting with moderate to severe fibrosis, 4/9(44.4%) HCV carriers and 8/65(12.3%) excessive alcohol consumers. HBV vaccination was given to 81/149(54.4%) individuals with no serological markers. A total of nine HIV tests were conducted at the 57 discharge consultations, involving 215 detainees being released, all of which were negative. CONCLUSION: The promotion of these evaluations proved beneficial, although viral screening could be achieved for only approaching half of the detainees, as could alcohol consumption assessment and HBV vaccination for those concerned. Fibrosis screening revealed lesions in HCV carriers yet also in heavy drinkers, who are typically less likely to be assessed. Consultations and HIV screening on release were found to be rarely possible.
OBJECTIVES: In 2010 only 30.9%, of the Puy-de-Dome prison detainees were screened for human immunodeficiency virus (HIV), hepatitis C virus (HCV) and hepatitis B virus (HBV). Our goal was then to promote these assesments, as well as to identify addictive behaviour using FAGERSTROM, Cannabis Abuse Screening Test and CAGE tests, diagnose fibrosis by means of Fibrometer or Fibroscan in hepatic virus carriers and heavy drinkers, and perform HBV vaccinations. SETTING: This prospective study of adult detainees in the prisons of Puy-de-Dome, France, took place from June 2012 to December 2013. RESULTS: Of the 702 incarcerated individuals, 396(56.4%) were screened and 357(50.9%) enrolled. HIV prevalence was 0.3%, HCV 4.7% and HBV 0.6%. While 234/294(79.6%) smokers and 115/145(79.3%) cannabis users were screened for dependence, excessive alcohol consumption was tested for in 91/179(50.8%) cases. Fibrosis was screened for in 75/80(93.7%) individuals selected with 16.0% presenting with moderate to severe fibrosis, 4/9(44.4%) HCV carriers and 8/65(12.3%) excessive alcohol consumers. HBV vaccination was given to 81/149(54.4%) individuals with no serological markers. A total of nine HIV tests were conducted at the 57 discharge consultations, involving 215 detainees being released, all of which were negative. CONCLUSION: The promotion of these evaluations proved beneficial, although viral screening could be achieved for only approaching half of the detainees, as could alcohol consumption assessment and HBV vaccination for those concerned. Fibrosis screening revealed lesions in HCV carriers yet also in heavy drinkers, who are typically less likely to be assessed. Consultations and HIV screening on release were found to be rarely possible.
Authors: S Desai; L Tavoschi; A K Sullivan; L Combs; D Raben; V Delpech; S F Jakobsen; A J Amato-Gauci; S Croxford Journal: HIV Med Date: 2019-11-14 Impact factor: 3.180
Authors: Anne C Spaulding; Gloria D Eldridge; Cynthia E Chico; Nancy Morisseau; Ana Drobeniuc; Rebecca Fils-Aime; Carolyn Day; Robyn Hopkins; Xingzhong Jin; Junyu Chen; Kate A Dolan Journal: Epidemiol Rev Date: 2018-06-01 Impact factor: 6.222
Authors: Nancy Vicente-Alcalde; Jose Tuells; Cecilia M Egoavil; Esther Ruescas-Escolano; Cesare Altavilla; Pablo Caballero Journal: Int J Environ Res Public Health Date: 2020-10-31 Impact factor: 3.390
Authors: Nancy Vicente-Alcalde; Esther Ruescas-Escolano; Zitta Barrella Harboe; José Tuells Journal: Int J Environ Res Public Health Date: 2020-10-19 Impact factor: 3.390